Astrazeneca (AZN) Exchange Rate Effect (2009 - 2026)

Astrazeneca (AZN) has reported Exchange Rate Effect for 17 consecutive years, with -$18.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Exchange Rate Effect fell 172.0% year-over-year to -$18.0 million; the TTM figure through Mar 2026 stood at $3.0 million (up 113.64% YoY), while the FY2025 annual figure was $46.0 million, up 149.46% from the prior year.
• Exchange Rate Effect came in at -$18.0 million for Q1 2026 at Astrazeneca, down from $4.0 million in the prior quarter.
• The five-year high for Exchange Rate Effect was $29.0 million in Q2 2025, with the low at -$61.0 million in Q4 2024.
• Average Exchange Rate Effect over 5 years is -$11.3 million, with a median of -$11.0 million recorded in 2023.
• Across the five-year window, Exchange Rate Effect plunged 318.18% in 2024 and jumped 583.33% in 2025, its largest moves.
• Year by year, Exchange Rate Effect stood at -$26.0 million in 2022, then plunged by 38.46% to -$36.0 million in 2023, then plunged by 69.44% to -$61.0 million in 2024, then surged by 106.56% to $4.0 million in 2025, then tumbled by 550.0% to -$18.0 million in 2026.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered -$18.0 million, $4.0 million, and -$12.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.